Skip to main content
. 2018 Feb 22;5(1):171–183. doi: 10.1007/s40744-018-0096-4

Table 1.

Patient characteristic before and after matching

Characteristics Before matching After matching
All RA/depression RA only Standardized difference All RA/depression RA only Standardized difference
N = 7311 N = 473 N = 6838 N = 2270 N = 454 N = 1816
Gender
 Female 5391 (73.74%) 375 (79.28%) 5016 (73.35%) 0.14121* 1799 (79.25%) 358 (78.85%) 1441 (79.35%) − 0.01219
 Male 1920 (26.26%) 98 (20.72%) 1822 (26.65%) 471 (20.75%) 96 (21.15%) 375 (20.65%)
Age at index-date
 Mean (Sd) 51.93 (10.94) 52.55 (10.72) 51.89 (10.95) 0.06128 52.64 (10.91) 52.41 (10.68) 52.70 (10.97) − 0.02664
 Min–Max [18.0; 75.0] [21.0; 75.0] [18.0; 75.0] [18.0; 75.0] [21.0; 75.0] [18.0; 75.0]
 Median 53 53 53 54 53 54
 Q1–Q3 [44.0; 60.0] [46.0; 60.0] [44.0; 60.0] [45.0; 60.0] [46.0; 60.0] [45.0; 60.0]
Calendar year of index date
 2010 1471 (20.12%) 59 (12.47%) 1412 (20.65%) 0.36993* 277 (12.20%) 59 (13.00%) 218 (12.00%) 0.04186
 2011 716 (9.79%) 46 (9.73%) 670 (9.80%) 232 (10.22%) 46 (10.13%) 186 (10.24%)
 2012 728 (9.96%) 56 (11.84%) 672 (9.83%) 268 (11.81%) 53 (11.67%) 215 (11.84%)
 2013 2739 (37.46%) 147 (31.08%) 2592 (37.91%) 720 (31.72%) 147 (32.38%) 573 (31.55%)
 2014 1001 (13.69%) 82 (17.34%) 919 (13.44%) 403 (17.75%) 78 (17.18%) 325 (17.90%)
 2015 656 (8.97%) 83 (17.55%) 573 (8.38%) 370 (16.30%) 71 (15.64%) 299 (16.46%)
Follow-up duration in months
 Mean (Sd) 31.08 (19.23) 27.37 (18.97) 31.34 (19.22) 0.08418 27.69 (18.35) 28.07 (18.92) 27.59 (18.21) 0.01201
 Min–Max [1.0; 71.0] [1.0; 71.0] [1.0; 68.0] [1.0; 71.0] [1.0; 71.0] [1.0; 68.0]
 Median 29 27 29 28 27 28
 Q1–Q3 [17.0; 42.0] [11.0; 37.0] [17.0; 43.0] [13.0; 38.0] [12.0; 38.0] [13.0; 39.0]
Charlson comorbidity index (CCI)
 Mean (Sd) 2.08 (1.77) 2.25 (2.42) 2.07 (1.71) − 0.20821* 2.12 (1.84) 2.14 (2.28) 2.12 (1.71) 0.02562
 Min–Max [0.0; 19.0] [0.0; 16.0] [1.0; 19.0] [0.0; 15.0] [0.0; 12.0] [1.0; 15.0]
 Median 1 2 1 1 2 1
 Q1–Q3 [1.0; 3.0] [1.0; 3.0] [1.0; 3.0] [1.0; 3.0] [0.0; 3.0] [1.0; 3.0]
Renal failure
 Yes 97 (1.33%) 12 (2.54%) 85 (1.24%) 0.09513 41 (1.81%) 8 (1.76%) 33 (1.82%) − 0.00415
 No 7214 (98.67%) 461 (97.46%) 6753 (98.76%) 2229 (98.19%) 446 (98.24%) 1783 (98.18%)
Interstitial pneumonia
 Yes 167 (2.28%) 10 (2.11%) 157 (2.30%) − 0.01238 48 (2.11%) 10 (2.20%) 38 (2.09%) 0.0076
 No 7144 (97.72%) 463 (97.89%) 6681 (97.70%) 2222 (97.89%) 444 (97.80%) 1778 (97.91%)
COPD
 Yes 665 (9.10%) 73 (15.43%) 592 (8.66%) 0.20931* 315 (13.88%) 59 (13.00%) 256 (14.10%) − 0.03219
 No 6646 (90.90%) 400 (84.57%) 6246 (91.34%) 1955 (86.12%) 395 (87.00%) 1560 (85.90%)
Peptic ulcer
 Yes 14 (0.19%) 1 (0.21%) 13 (0.19%) 0.00476 3 (0.13%) 1 (0.22%) 2 (0.11%) 0.02712
 No 7297 (99.81%) 472 (99.79%) 6825 (99.81%) 2267 (99.87%) 453 (99.78%) 1814 (99.89%)
Chronic liver disease
 Yes 68 (0.93%) 4 (0.85%) 64 (0.94%) − 0.00961 19 (0.84%) 4 (0.88%) 15 (0.83%) 0.00599
 No 7243 (99.07%) 469 (99.15%) 6774 (99.06%) 2251 (99.16%) 450 (99.12%) 1801 (99.17%)
Osteoporosis
 Yes 2000 (27.36%) 145 (30.66%) 1855 (27.13%) 0.07789 656 (28.90%) 133 (29.30%) 523 (28.80%) 0.01092
 No 5311 (72.64%) 328 (69.34%) 4983 (72.87%) 1614 (71.10%) 321 (70.70%) 1293 (71.20%)
Diabetes
 Yes 1965 (26.88%) 122 (25.79%) 1843 (26.95%) 0.03853 540 (23.79%) 114 (25.11%) 426 (23.46%) 0.03853
 No 5346 (73.12%) 351 (74.21%) 4995 (73.05%) 1730 (76.21%) 340 (74.89%) 1390 (76.54%)

*Absolute standardized differences > 10%